06/23/2026
Meet Dr. Alison Schram, a medical oncologist whose vision was backed early by Conquer Cancer funding. 🧬
Dr. Schram chose to look past the physical location of a tumor to focus entirely on its genetics. Specifically, she investigated ultra-rare genetic fusions that act like "stuck accelerators," causing cancer cells to grow out of control. Her dedication resulted in a major medical milestone: an expanded FDA approval for a targeted drug that successfully treats rare, aggressive lung, pancreatic, and bile duct cancers sharing this exact genetic trait. For patients like Ahmet—a father who saw his tumors shrink by roughly 50% on Dr. Schram's clinical trial—this research isn't just a headline. It is a future. 🧡 https://bit.ly/4w3vLKZ